AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?
Authors: Visco, C Medeiros, LJ Mesina, OM Rodriguez, MA Hagemeister, FB McLaughlin, P Romaguera, JE Cabanillas, F Sarris, AH
Citation: C. Visco et al., Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?, CLIN LYMPHO, 2(1), 2001, pp. 40-46
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody1F7 on human CD30+anaplastic large cell T-cell lymphoma Karpas 299
Authors: Ho, L Aytac, U Stephens, LC Ohnuma, K Mills, GB McKee, KS Neumann, C LaPushin, R Cabanillas, F Abbruzzese, JL Morimoto, C Dang, NH
Citation: L. Ho et al., In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody1F7 on human CD30+anaplastic large cell T-cell lymphoma Karpas 299, CLIN CANC R, 7(7), 2001, pp. 2031-2040
Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: Results with ALK-11 antibody in 327 untreated patients
Authors: Herling, M Rassidakis, GZ Viviani, S Bonfante, V Giardini, R Gianni, M Morris, SW Cabanillas, F Medeiros, LJ Sarris, AH
Citation: M. Herling et al., Anaplastic lymphoma kinase (ALK) is not expressed in Hodgkin's disease: Results with ALK-11 antibody in 327 untreated patients, LEUK LYMPH, 42(5), 2001, pp. 969
Hodgkin's disease in patients infected with human immunodeficiency virus: Frequency, presentation and clinical outcome
Authors: Tsimberidou, AM Sarris, AH Medeiros, LJ Mesina, O Rodriguez, MA Hagemeister, FB Romaguera, J Pro, B McLaughlin, P Dang, N Cabanillas, F
Citation: Am. Tsimberidou et al., Hodgkin's disease in patients infected with human immunodeficiency virus: Frequency, presentation and clinical outcome, LEUK LYMPH, 41(5-6), 2001, pp. 535-544
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus
Authors: Rodriguez, J Romaguera, JE Katz, RL Said, J Cabanillas, F
Citation: J. Rodriguez et al., Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus, LEUK LYMPH, 41(1-2), 2001, pp. 185-189
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Authors: Younes, A Preti, HA Hagemeister, FB McLaughlin, P Romaguera, JE Rodriguez, MA Samuels, BI Palmer, JL Cabanillas, F
Citation: A. Younes et al., Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma, ANN ONCOL, 12(7), 2001, pp. 923-927
Clinical impact of rituximab in managing B-cell lymphomas
Authors: Grillo-Lopez, AJ McLaughlin, P Wey, K Dallaire, BK Nasazideh, H Eldredge, E Leonerd, JE White, CA Cabanillas, F
Citation: Aj. Grillo-lopez et al., Clinical impact of rituximab in managing B-cell lymphomas, ONCOLOGY-NY, 15(3), 2001, pp. 11
Immunotherapy for non-Hodgkin's lymphoma - The Vose article reviewed
Authors: Cabanillas, F
Citation: F. Cabanillas, Immunotherapy for non-Hodgkin's lymphoma - The Vose article reviewed, ONCOLOGY-NY, 15(2), 2001, pp. 152-153
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: Preferential cutaneous relapses but high cure rate with doxorubicin-based therapy
Authors: Sarris, AH Braunschweig, I Medeiros, LJ Duvic, M Ha, CS Rodriguez, MA Hagemeister, FB McLaughlin, P Romaguera, J Cox, J Cabanillas, F
Citation: Ah. Sarris et al., Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: Preferential cutaneous relapses but high cure rate with doxorubicin-based therapy, J CL ONCOL, 19(2), 2001, pp. 398-405
Long-term results with radiotherapy for stage I-II follicular lymphomas
Authors: Wilder, RB Jones, D Tucker, SL Fuller, LM Ha, CS McLaughlin, P Hess, MA Cabanillas, F Cox, JD
Citation: Rb. Wilder et al., Long-term results with radiotherapy for stage I-II follicular lymphomas, INT J RAD O, 51(5), 2001, pp. 1219-1227
Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: Long-term follow-up and patterns of failure
Authors: Liao, ZX Ha, CS Vlachaki, MT Hagemeister, F Cabanillas, F Hess, M Tucker, S Cox, JD
Citation: Zx. Liao et al., Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: Long-term follow-up and patterns of failure, INT J RAD O, 50(4), 2001, pp. 971-977
The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21)
Authors: Ha, CS Tucker, SL Lee, MS McLaughlin, P Cabanillas, F Cox, JD
Citation: Cs. Ha et al., The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21), INT J RAD O, 49(3), 2001, pp. 727-732
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival
Authors: van Besien, K Rodriguez, A Tomany, S Younes, A Donate, M Sarris, A Giralt, S Mehra, R Andersson, B Gajewski, J Champlin, R Cabanillas, F
Citation: K. Van Besien et al., Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival, BONE MAR TR, 27(4), 2001, pp. 397-404
Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint
Authors: Aytac, U Claret, FX Ho, L Sato, K Ohnuma, K Mills, GB Cabanillas, F Morimoto, C Dang, NH
Citation: U. Aytac et al., Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint, CANCER RES, 61(19), 2001, pp. 7204-7210
Primary hepatic lymphoma - Favorable outcome after combination chemotherapy
Authors: Page, RD Romaguera, JE Osborne, B Medeiros, LJ Rodriguez, J North, L Sanz-Rodriguez, C Cabanillas, F
Citation: Rd. Page et al., Primary hepatic lymphoma - Favorable outcome after combination chemotherapy, CANCER, 92(8), 2001, pp. 2023-2029
Hematologic recovery after central lymphatic irradiation for patients withstage I-II follicular lymphoma
Authors: Ha, CS Tucker, SL Blanco, AI Wilder, RB McLaughlin, P Cabanillas, F Cox, JD
Citation: Cs. Ha et al., Hematologic recovery after central lymphatic irradiation for patients withstage I-II follicular lymphoma, CANCER, 92(5), 2001, pp. 1074-1079
Treatment of unicentric and multicentric Castleman disease and the role ofradiotherapy
Authors: Chronowski, M Ha, CS Wilder, RB Cabanillas, F Manning, J Cox, JD
Citation: M. Chronowski et al., Treatment of unicentric and multicentric Castleman disease and the role ofradiotherapy, CANCER, 92(3), 2001, pp. 670-676
Localized non-Hodgkin lymphoma involving the thyroid gland
Authors: Ha, CS Shadle, KM Medeiros, LJ Wilder, RB Hess, MA Cabanillas, F Cox, JD
Citation: Cs. Ha et al., Localized non-Hodgkin lymphoma involving the thyroid gland, CANCER, 91(4), 2001, pp. 629-635
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma
Authors: Wilder, RB Rodriguez, MA Ha, CS Pro, B Hess, MA Cabanillas, F Cox, JD
Citation: Rb. Wilder et al., Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma, CANCER, 91(12), 2001, pp. 2440-2446
Functional expression of receptor activator of nuclear factor kappa B in Hodgkin disease cell lines
Authors: Fiumara, P Snell, V Li, Y Mukhopadhyay, A Younes, M Gillenwater, AM Cabanillas, F Aggarwal, BB Younes, A
Citation: P. Fiumara et al., Functional expression of receptor activator of nuclear factor kappa B in Hodgkin disease cell lines, BLOOD, 98(9), 2001, pp. 2784-2790
Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers
Authors: Fiumara, P Cabanillas, F Younes, A
Citation: P. Fiumara et al., Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers, BLOOD, 98(9), 2001, pp. 2877-2878
Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage
Authors: Rassidakis, GZ Sarris, AH Herling, M Ford, RJ Cabanillas, F McDonnell, TJ Medeiros, LJ
Citation: Gz. Rassidakis et al., Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage, AM J PATH, 159(2), 2001, pp. 527-535
Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma
Authors: Younes, A Cristofanilli, M McLaughlin, P Hagemeister, FB Weber, D Mesina, O Cabanillas, F
Citation: A. Younes et al., Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma, LEUK LYMPH, 40(1-2), 2000, pp. 79-85
Infusional vinorelbine in relapsed or refractory lymphomas
Authors: Sarris, AH Psyrri, A Hagemeister, F Romaguera, J McLaughlin, P Rodriguez, MA Bachier, C Younes, A Mesina, O Oholendt, M Medeiros, LJ Samuels, B Adams, LM Cabanillas, F
Citation: Ah. Sarris et al., Infusional vinorelbine in relapsed or refractory lymphomas, LEUK LYMPH, 39(3-4), 2000, pp. 291-299
Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients
Authors: Romaguera, JE Khouri, IF Kantarjian, HM Hagemeister, FB Rodriguez, MA McLaughlin, P Sarris, AH Younes, A Rodriguez, J Cabanillas, F
Citation: Je. Romaguera et al., Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients, LEUK LYMPH, 39(1-2), 2000, pp. 77-85
Risultati: 1-25 | 26-50 | 51-54